Moderna Has a New, “Well Tolerated” Omicron Booster—Here’s What We Know About It

Published June 9, 2022

Yahoo! and MSN quoted Thomas A. Russo, MD, SUNY Distinguished Professor of medicine and chief of the Division of Infectious Diseases, for a story about a new COVID-19 vaccine booster candidate from Moderna that targets Omicron variants. Russo pointed out that while COVID-19 vaccines have done a good job of keeping most fully vaccinated people from developing severe symptoms, being hospitalized and dying, they are still “imperfect.” “The hope is that, if we have variant-specific vaccines, that will do a better job at infection prevention and perhaps a whiff better at preventing hospitalizations and deaths,” Russo said.